Insider filing · RLAY
Donald A Bergstrom
President, R&D
profile →
Relay Therapeutics, Inc.
RLAY · Healthcare · 32 filings in 24 months
ticker →
Donald A Bergstrom sold $1.6M of Relay Therapeutics (RLAY)
Executed Jun 22, disclosed Jun 24, 2 days later.
Value, as filed
$1.6M
93,456 sh × $16.94
Executed
Jun 22
the trade date, as filed
Disclosed
Jun 24
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
DBDonald A Bergstrom (President, R&D) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in Relay Therapeutics, Inc. (RLAY). The largest single filing was $1.6M of RLAY (93,456 sh × $16.94, as filed), executed Jun 22.
The name
RLAYHealthcare · Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Donald A Bergstrom in RLAY
RLAYSALE
Relay Therapeutics, Inc.
$162K8,530 sh × $18.97
Exec Sep 8
Filed Sep 9 · 4:17 PM ET RLAYSALE Relay Therapeutics, Inc. $162K
8,660 sh × $18.71
Exec Jul 6
Filed Jul 8 · 5:11 PM ET RLAYSALE Relay Therapeutics, Inc. $144K
18,895 sh × $7.62
Exec Jan 27
Filed Jan 29 · 5:30 PM ET RLAYSALE Relay Therapeutics, Inc. $225K
30,897 sh × $7.29
Exec Oct 28 2025
Filed Oct 30 2025 · 5:30 PM ET RLAYSALE Relay Therapeutics, Inc. $347K
77,230 sh across 2 lots
Exec Jan 29 2025
Filed Jan 30 2025 · 5:30 PM ET